Literature DB >> 18351626

Characterization of amorphous API:Polymer mixtures using X-ray powder diffraction.

Ann Newman1, David Engers, Simon Bates, Igor Ivanisevic, Ron C Kelly, George Zografi.   

Abstract

Recognizing limitations with the standard method of determining whether an amorphous API-polymer mixture is miscible based on the number of glass transition temperatures (T(g)) using differential scanning calorimetry (DSC) measurements, we have developed an X-ray powder diffraction (XRPD) method coupled with computation of pair distribution functions (PDF), to more fully assess miscibility in such systems. The mixtures chosen were: dextran-poly(vinylpyrrolidone) (PVP) and trehalose-dextran, both prepared by lyophilization; and indomethacin-PVP, prepared by evaporation from organic solvent. Immiscibility is detected when the PDF profiles of each individual component taken in proportion to their compositions in the mixture agree with the PDF of the mixture, indicating phase separation into independent amorphous phases. A lack of agreement of the PDF profiles indicates that the mixture with a unique PDF is miscible. In agreement with DSC measurements that detected two independent T(g) values for the dextran-PVP mixture, the PDF profiles of the mixture matched very well indicating a phase separated system. From the PDF analysis, indomethacin-PVP was shown to be completely miscible in agreement with the single T(g) value measured for the mixture. In the case of the trehalose-dextran mixture, where only one T(g) value was detected, however, PDF analysis clearly revealed phase separation. Since DSC can not detect two T(g) values when phase separation produces amorphous domains with sizes less than approximately 30 nm, it is concluded that the trehalose-dextran system is a phase separated mixture with a structure equivalent to a solid nanosuspension having nanosize domains. Such systems would be expected to have properties intermediate to those observed for miscible and macroscopically phase separated amorphous dispersions. However, since phase separation has occurred, the solid nanosuspensions would be expected to exhibit a greater tendency for physical instability under a given stress, that is, crystallization, than would a miscible system.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18351626     DOI: 10.1002/jps.21352

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  18 in total

1.  Structural interpretation in composite systems using powder X-ray diffraction: applications of error propagation to the pair distribution function.

Authors:  Michael D Moore; Zhenqi Shi; Peter L D Wildfong
Journal:  Pharm Res       Date:  2010-09-02       Impact factor: 4.200

2.  Solution behavior of PVP-VA and HPMC-AS-based amorphous solid dispersions and their bioavailability implications.

Authors:  Feng Qian; Jennifer Wang; Ruiling Hartley; Jing Tao; Raja Haddadin; Neil Mathias; Munir Hussain
Journal:  Pharm Res       Date:  2012-10       Impact factor: 4.200

3.  A structural investigation into the compaction behavior of pharmaceutical composites using powder X-ray diffraction and total scattering analysis.

Authors:  Michael D Moore; Alison M Steinbach; Ira S Buckner; Peter L D Wildfong
Journal:  Pharm Res       Date:  2009-08-28       Impact factor: 4.200

4.  Data requirements for the reliable use of atomic pair distribution functions in amorphous pharmaceutical fingerprinting.

Authors:  Timur Dykhne; Ryan Taylor; Alastair Florence; Simon J L Billinge
Journal:  Pharm Res       Date:  2011-01-08       Impact factor: 4.200

5.  Insights into Nano- and Micron-Scale Phase Separation in Amorphous Solid Dispersions Using Fluorescence-Based Techniques in Combination with Solid State Nuclear Magnetic Resonance Spectroscopy.

Authors:  Hitesh S Purohit; James D Ormes; Sugandha Saboo; Yongchao Su; Matthew S Lamm; Amanda K P Mann; Lynne S Taylor
Journal:  Pharm Res       Date:  2017-04-28       Impact factor: 4.200

6.  In vitro and in vivo evaluation of amorphous solid dispersions generated by different bench-scale processes, using griseofulvin as a model compound.

Authors:  Po-Chang Chiang; Yong Cui; Yingqing Ran; Joe Lubach; Kang-Jye Chou; Linda Bao; Wei Jia; Hank La; Jonathan Hau; Amy Sambrone; Ann Qin; Yuzhong Deng; Harvey Wong
Journal:  AAPS J       Date:  2013-03-02       Impact factor: 4.009

7.  Molecular weight effects on the miscibility behavior of dextran and maltodextrin with poly(vinylpyrrolidone).

Authors:  Bernard Van Eerdenbrugh; Lynne S Taylor
Journal:  Pharm Res       Date:  2012-10       Impact factor: 4.200

8.  Evaluation of drug-polymer miscibility in amorphous solid dispersion systems.

Authors:  Alfred C F Rumondor; Igor Ivanisevic; Simon Bates; David E Alonzo; Lynne S Taylor
Journal:  Pharm Res       Date:  2009-09-22       Impact factor: 4.200

9.  Solid-state characterization of Felodipine-Soluplus amorphous solid dispersions.

Authors:  Jiannan Lu; Kristina Cuellar; Nathan I Hammer; Seongbong Jo; Andreas Gryczke; Karl Kolter; Nigel Langley; Michael A Repka
Journal:  Drug Dev Ind Pharm       Date:  2015-11-04       Impact factor: 3.225

10.  Drug crystal growth in ternary amorphous solid dispersions: Effect of surfactants and polymeric matrix-carriers.

Authors:  Afroditi Kapourani; Theodora Tzakri; Vasiliki Valkanioti; Konstantinos N Kontogiannopoulos; Panagiotis Barmpalexis
Journal:  Int J Pharm X       Date:  2021-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.